EglN2 associates with the NRF1‐PGC1α complex and controls mitochondrial function in breast cancerJing Zhang, Qing Zhang, Haitao Wen et al.|The EMBO Journal|2015Cited by 72
Identification of BBOX1 as a Therapeutic Target in Triple-Negative Breast CancerChengheng Liao, Qing Zhang, Yang Zhang et al.|Cancer Discovery|2020Cited by 68
Prolyl hydroxylase substrate adenylosuccinate lyase is an oncogenic driver in triple negative breast cancerGiada Zurlo, Qing Zhang, Xijuan Liu et al.|Nature Communications|2019Cited by 48